Hide Board Information

Show Board Information

Aquestive Therapeutics Inc. AQST

Board Mod: Add me as mod

Asst Mods:

Last Post: 08/12/2022 4:48:36 PM

Board Marks: 1

Posts Today: 0

Board Views Today: 4

Aquestive Therapeutics Inc. (NASDAQ: AQST) Stock Message Board

1. AQST Company Profile

    

2. AQST Time & Sales

    

3. AQST Recent News

    

4. AQST Filings

    

5. AQST Financials

    

6. AQST Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	AQST 24% v2,2M c1.73 f53,4M H1.78 ML.78 LL.62	znewcar1	08/12/2022 4:48:36 PM
7	AQSRI - Price Drop	J L	12/21/2021 2:52:42 PM
6	AQST - Monday Rundown, Tuesday Expectations	J L	12/20/2021 11:43:00 PM
5	AQST - FDA Approval Insight	J L	12/19/2021 3:40:09 PM
4	AQST - Tuesday Rundown, Wednesday Expectations	J L	11/30/2021 11:28:53 PM
3	AQST - Update	J L	10/15/2021 3:06:04 PM
2	AQST - Tuesday Rundown, Wednesday Expectations	J L	09/07/2021 11:45:19 PM
1	Look like target to $8-$10 after	Tomboston	05/16/2020 4:09:52 PM

Recent Articles

• Understanding Fulcrum Therapeutics' Recent Stock Option Grant
• Olema Oncology Highlights Investor Conference Participation Plans
• Vital Battery Metals Transitions to Aventis Energy Inc. Name Change
• Exploring Herzfeld Caribbean Basin Fund's Stock and Cash Strategy
• Summary of Source Energy Services Annual Meeting Outcomes
• Preferred Bank Welcomes New Leadership in Risk Management
• Lockheed Martin's Significant 2025 Dividend Announcement
• Vulcan Announces Cash Dividend for Common Stock Investors
• Leadership Updates at Steel Dynamics Craft Future Success
• Tactacam Teams Up with Barrett for Enhanced Fulfillment Solutions
• Coave Therapeutics Unveils coAAV-CSF-01: A Breakthrough in CNS Gene Therapy
• Nyxoah SA Reports New Transparency Notification Updates
• Twin Disc Inc. Declares New Dividend for Shareholders
• BioCardia Set to Share Key Updates and Financial Insights in 2025
• Exploring the Recent Class Action Against West Pharmaceutical Services
• Nortech Systems to Share Q1 2025 Financial Insights Soon
• Avenue Capital Group Responds to Recent Lawsuit Claims
• Denali Capital's New Deadline for Business Combination Explained
• Nauticus Robotics Sets Date for Q1 Earnings Conference Call
• BNY Mellon to Showcase Q2 2025 Financial Results
• Parks! America, Inc. Posts Strong Q2 Performance Results
• TDS to Host Live Stream of 2025 Shareholder Meeting Soon
• Navigator Gas Board Update: A Transition in Leadership
• Hamilton Beach Brands Boosts Dividend for Shareholders
• Mayors Unite Against Medicaid Cuts to Protect Public Safety
• NI Holdings, Inc. Achieves Steady Growth in Q1 Results
• Navigator Gas Sets 2025 Meeting to Shape Its Future Strategies
• Investor Rights Investigation on TaskUs, ProAssurance, and Mr. Cooper
• Okeanis Eco Tankers Corp. Q1 2025 Results Overview
• Volcon Inc. Showcases Growth and Financial Performance Insights
• Artisan Partners Asset Management Sees Growth in AUM to $164.4B
• Fancamp's New Settlement Deal and Growth Opportunities Ahead
• Replimune's Strategic Inducement Awards for New Talent Acquisition
• PDS Biotechnology's Stock Option Grant and Strategic Plans Ahead
• Vera Therapeutics Announces New Employee Stock Awards
• Exagen's Public Offering Success: $20.2 Million Raised for Growth
• 89bio's Strategic Employee Inducement Grants Enhancing Growth Potential
• Analyzing Nasdaq's Latest Short Interest Data and Trends
• Matador Technologies Introduces New Private Placement Funding
• Athira Pharma's Q1 2025 Financial Outcomes and Pipeline Insights
• Entera Bio Posts Strong First Quarter 2025 Results and Updates
• Tyson Foods Declares Strong Dividend Amid Growth Plans
• Discover Oculis' Annual General Meeting Invitation and Agenda
• Allarity Therapeutics Reports Significant Developments in Q1 2025
• Oculis Announces Upcoming Annual General Meeting Details
• TELA Bio Expands Workforce with New Restricted Stock Awards
• Surrozen's Q1 Financial Update: A Focus on Eye Health Advances
• Motorsport Games Inc. Shares Positive Q1 Financial Gains
• Elton John Receives QVC's First Icon Award for Excellence
• Class Action Lawsuit Against Nike NFTs: Investors Need to Act